P837: ELTROMBOPAG (EPAG) INDUCES HEMATOLOGIC RESPONSES FOR PATIENTS WITH POST-ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANT POOR GRAFT FUNCTION (POST-ALLO HSCT PGF): RESULTS OF THE ELTION STUDY IN SPAIN

• C. Vallejo,
• I. García,
• F. Sanchez Guijo,
• M. Cuesta,
• C. Solano,
• A. Sampol,
• T. Torrado,
• M. Vendranas,
• M. Marigil

Affiliations

C. Vallejo

1 University Hospital Donostia, San Sebastian, Spain, University Hospital Donostia, San Sebastian, Spain, Santiago de Compostela

I. García

2 Department of Hematology, University Hospital Santa Cruz y San Pau, Barcelona

F. Sanchez Guijo

3 Department of Hematology, University Hospital of Salamanca, Salamanca

M. Cuesta

4 Department of Hematology, Carlos Haya University Hospital, Malaga

C. Solano

5 Department of Hematology, Hospital Clinico de Valencia, Valencia

A. Sampol

6 Department of Hematology, University Hospital Son Espases, Palma de Mallorca

T. Torrado

7 Department of Hematology, University Hospital Alvaro Cunqueiro, Vigo

M. Vendranas

8 Medical Affairs Department, Novartis, Barcelona, Spain

M. Marigil

8 Medical Affairs Department, Novartis, Barcelona, Spain